Oncologic emergencies: New decade, new perspectives

AACN Advanced Critical Care

Volumn 22, Issue 4, 2011, Pages 337-348

  Demshar, Regan ^a   Vanek, Rachel ^a   Mazanec, Polly ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

critical care; oncologic emergencies; quality of life

Indexed keywords

EMERGENCY; HUMAN; NEOPLASM; QUALITY OF LIFE; REVIEW; RISK FACTOR;

EMERGENCIES; HUMANS; NEOPLASMS; QUALITY OF LIFE; RISK FACTORS;

EID: 81255134902     PISSN: 15597768     EISSN: 15597776     Source Type: Journal    
DOI: 10.1097/NCI.0b013e318230112b     Document Type: Article

References (48)

1. Halfdanarson TR, Hogan W, Moynihan TJ. Oncologic emergencies: Diagnosis and treatment. Mayo Clin Proc. 2006;81(6):835-848.
2. Ferrell BR, Grant M. Quality of Life Model. 2000. Duarte, CA: City of Hope National Medical Center. http://www prc.coh.org. Accessed June 10, 2011.
3. Cope DG. Metabolic emergencies. In: BH Gobel, S Triest- Roberston, WH Vogel, eds. Advanced Oncology Nursing Certification Review and Resource Manual. Pittsburgh, PA: ONS; 2009:547-598.
4. Brumbaugh HL. Structural oncologic emergencies. In: BH Gobel, S Triest-Roberston, WH Vogel, eds. Advanced Oncology Nursing Certification Review and Resource Manual. Pittsburgh, PA: ONS; 2009:599-636.
5. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: A randomized trial. Lancet. 2005;366:643-648.
6. Snow RM, Miller WC, Rice DL, Khalil A. Respiratory failure in cancer patients. JAMA. 1979;21(19):2039-2042.
7. Soares M, Salluh JIF, Spector N, Rocco JR. Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for-24 hours. Crit Care Med. 2005;33(3):520-526.
8. Pastores SM, Voight L. Acute respiratory failure in the patient with cancer: Diagnostic and management strategies. Crit Care Clin. 2010;26:21-40.
9. Azoulay E, Alberti C, Bornstain C, et al. Improved survival in cancer patients requiring mechanical ventilatory support: Impact of noninvasive mechanical ventilatory support. Crit Care Med. 2001;29(3):519-525.
10. Soares M, Depuydt P, Salluh JIF. Mechanical ventilation in cancer patients: Clinical characteristics and outcomes. Crit Care Clin. 2010;26:41-58.
11. Heit JA, Siverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: A population- based case-control study. Arch Intern Med. 2000;160:809-815.
12. DeSancho MT, Rand JH. Bleeding and thrombotic complications in critically ill patients with cancer. Crit Care Clin. 2001;17(3):599-622.
13. Nikolaou K, Thieme S, Sommer W, et al. Diagnosing pulmonary embolism: New computed tomography applications. J Thorac Imaging. 2010;25(2):151-160.
14. Abdel-Razeq H, Mansour A, Ismail Y, et al. Inferior vena cava filters in cancer patients: To filter or not to filter. Ther Clin Risk Manag. 2011;7:99-102.
15. Barginear M, Lesser M, Akerman M, et al. Need for inferior vena cava filters in cancer patients: A surrogate marker for poor outcome. Clin Appl Thromb Hemost. 2009;15(3):263-269.
16. Rubenfeld GD, Herridge MS. Epidemiology and outcomes of acute lung injury. Chest. 2007;131:554-562.
17. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome. N Engl J Med. 2000;42:1301-1308.
18. Shelton BK. Admission criteria and prognostication in patients with cancer admitted to the intensive care unit. Crit Care Clin. 2010;6:1-20.
19. Chang L, Horng CF, Huang YCT, et al. Prognostic accuracy of acute physiology and chronic health evaluation II scores in critically ill cancer patients. Am J Crit Care. 2006;15(1):47-53.
20. Groger JS, Lemeshow S, Price K, et al. Multicenter outcome study of cancer patients admitted to the intensive care unit: A probability of mortality model. J Clin Oncol. 1998;16:761-770.
21. Higdon ML, Higdon JA. Treatment of oncologic emergencies. Am Fam Phys. 2006;1873-1880.
22. Held-Warmkessel J. Cardiac, gastrointestinal, neurologic, and ocular toxicities. In: Gobel BH, Triest-Roberston S, Vogel WH, eds. Advanced Oncology Nursing Certification Review and Resource Manual. Pittsburgh, PA: ONS; 2009:443-494.
23. Van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22(2):209-224.
24. Bent S, Goldberg H, Padula A, et al. Spontaneous bleeding associated with ginkgo biloba: A case report and systematic review of the literature. J Gen Intern Med. 2005;20(7):657-661.
25. Yarris JP, Warden CR. Gastrointestinal bleeding in the cancer patient. Emerg Med Clinic N Am. 2009;27:363-379.
26. Wilkes GM. Colon, rectal, and anal cancers. In: Yarbro CH, Wujcik D, Gobel BH, eds. Cancer Nursing: Principles and Practice. 7th ed. Sudbury, MA: Jones & Bartlett; 2011:1205-1257.
27. Imbesi JJ, Kurtz RC. A multidisciplinary approach to gastrointestinal bleeding in cancer patients. J Support Oncol. 2005;3(2):101-110.
28. Ranpura V, Hapani S, Wu S. Treatment-related mortality with bevacizumab in cancer patients. JAMA. 2011;305(5): 487-494.
29. Heller SJ, Tokar JL, Nguyen MT, et al. Management of bleeding GI tumors. Gastrointest Endosc. 2010;72(4): 817824.
30. Gould S, Cimino MJ, Gerber D. Packed red blood cell transfusion in the intensive care unit: Limitations and consequences. Am J Crit Care. 2007;16(1):39-50.
31. Spivak, J, Gasson P, Ludwig H. Anemia management in oncology and hematology. Oncologist. 2009;14:43-52.
32. Levi M. Disseminated intravascular coagulation in cancer patients. Best Pract Res Clin Haematol. 2009;22(1):129-136.
33. Kvolik S, Jukic M, Matijevic M, et al. An overview of coagulation disorders in cancer patients. Surg Oncol. 2010;19(1):e33-e46.
34. Kitchens CS. Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC). Hematology Am Soc Hematol Educ Program. 2009:240-246.
35. Becker JU, Wira CR. Disseminated intravascular coagulation. http://www.emedicine.com/emerg/TOPIC150.htm. Published March 2008. Accessed June 22, 2011.
36. O'Leary C. Septic shock. In: Yarbro CH, Wujcik D, Gobel BH, eds. Cancer Nursing: Principles and Practice. 7th ed. Sudbury, MA: Jones & Bartlett; 2011:964-978.
37. Nirenberg A, Bush AP, Davis A. Neutropenia: State of the knowledge Part II. Oncol Nurs Forum. 2006;33:1202-1208.
38. NCI common terminology for adverse events. http://evs nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14-Quick-Reference-8.5x11.pdf. Accessed July 6, 2011.
39. Infectious Diseases Society of America Guidelines http://www.idsociety. org/content.aspx?id=9088. Accessed July 7, 2011.
40. Ramzi J, Mohamed Z, Yosr B, et al. Predictive factors of septic shock and mortality in neutropenic patients. Hematology. 2007;12:543-548.
41. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427-431.
42. Sepsis guidelines. http://www.survivingsepsis.org/Bundles/ Pages/default.aspx. Accessed June 10, 2011.
43. Weil MH. Defining hemodynamic instability. Update Inten Care Emerg Med. 2005;42:9-17.
44. Ferra C, Marcos P, Misis M, et al. Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: A single-center experience. Int J Hematol. 2007;85(3):195-202.
45. Camp-Sorrell D. Chemotherapy toxicities and management. In: Yarbro CH, Wujcik D, Gobel BH, eds. Cancer Nursing: Principles and Practice. 7th ed. Sudbury MA: Jones & Bartlett; 2011:458-503.
46. Behl D, Hendrickson AW, Moynihan TJ. Oncologic emergencies. Crit Care Clin. 2010;26:181-205.
47. Lee C, Gianos M, Klaustermeyer WB. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents. Ann Allergy Asthma Immunol. 2009;102:179-187.
48. Swartz RN, Stover L, Dutcher J. Managing toxicities of highdose interleukin-2. Oncology. 2002;16(suppl 13):11-20.